Sector News

Amgen appoints senior VP and head of the European region

June 16, 2015
Life sciences
Amgen has named Corinne Le Goff as senior vice president and head of the European region.
 
Effective from June 1, Le Goff will be responsible for leading Amgen’s growth in Europe and will report directly to executive VP of global commercial operations, Anthony Hooper.
 
Commenting on her appointment, Le Goff said: “This is a pivotal moment for Amgen with a number of innovative new compounds either in the late stage clinical research or under review by the European regulatory authorities. 
 
“I am delighted to have the opportunity to lead the team in Europe at this exciting time.”
 
Le Goff joins from Roche, where she most recently served as president since 2012. In the role, she successfully led the business and a team of over 1,200 staff and helped evolve the business into one with a greater focus on market access and key account management.
 
Previously, Le Goff spent five years in strategic commercial leadership roles managing therapeutic areas at Roche, where she was senior VP of global product strategy for the neurosciences franchise and at Merck Serono, where she was senior VP of strategy and global marketing for neurology, rheumatology and immunology.
 
Hooper added: “Corinne brings strong vision and leadership to our European operations based on her broad strategic and operational experience in large healthcare organisations at both the global and affiliate level. I am delighted to welcome her to the team”.
 
Source: Amgen

comments closed

Related News

October 2, 2022

GSK names Julie Brown, a 25-year AstraZeneca veteran, its first woman CFO

Life sciences

Five years ago, GSK made headlines when it hired Emma Walmsley to become the first woman to run a major pharmaceutical company. Now the Big Pharma has brought in another woman to control the company’s finances. Julie Brown will be GSK’s next chief financial officer. Brown, currently the chief operating and financial officer at fashion and beauty brand Burberry Group, is set to replace Iain Mackay.

October 2, 2022

Moderna creates new launch preparation role, poaches Novartis exec as manufacturing lead

Life sciences

Moderna created a new role responsible for “building out the company’s organization to support its growing pipeline.” Starting first thing 2023, Juan Andres, Moderna’s manufacturing head, will step into this new role under the title president of strategic partnerships and enterprise expansion, the company said Thursday.

October 2, 2022

Torrent Pharma to acquire Curatio for $245.16m

Life sciences

The latest takeover is anticipated to boost the presence of Torrent in the dermatology segment. Indian company Torrent Pharmaceuticals has signed a definitive agreement for the complete acquisition of Curatio Healthcare for $245.16m (Rs20bn).